Budesonide/albuterol sulfate metered-dose inhaler 160/180 μg

COMBINATION_PRODUCT2 trials

Sponsors

Bond Avillion 2 Development LP

Conditions

AsthmaExercise Induced Bronchospasm

Phase 3

A Study to Assess the Efficacy and Safety of Budesonide/Albuterol Metered-dose Inhaler (BDA MDI/PT027) in Adults and Children 4 Years of Age or Older With Asthma

CompletedNCT03769090

Bond Avillion 2 Development LPAsthma

Start: 2018-12-13End: 2022-02-07Updated: 2022-09-28

A Study to Assess the Efficacy of Budesonide/Albuterol Metered-dose Inhaler (BDA MDI/PT027) on Exercise-induced Bronchoconstriction in Adults and Adolescents With Asthma

CompletedNCT04234464

Bond Avillion 2 Development LPExercise Induced Bronchospasm

Start: 2020-01-15End: 2020-08-28Updated: 2022-01-13

Related Papers

Albuterol–budesonide rescue inhaler for asthma

Annals of Allergy Asthma & Immunology2025-07-15

As-needed Albuterol-budesonide Decreases Risk of Severe Asthma Exacerbation in the First Three Months Post-randomization Compared to As-needed Albuterol in Patients Treated for Moderate-to-Severe Asthma: MANDALA Post-Hoc Analysis

American Journal of Respiratory and Critical Care Medicine2025-05-01

Corticosteroid-associated Systemic Adverse Events in Patients on Background Inhaled Corticosteroid Maintenance Therapy and Taking Albuterol-Budesonide Versus Albuterol as Rescue: Post-hoc Analysis of MANDALA

American Journal of Respiratory and Critical Care Medicine2025-05-01

Albuterol–budesonide asthma rescue inhaler: patterns of as-needed use

2023-09-09

Albuterol–Budesonide Fixed-Dose Combination Rescue Inhaler for Asthma

New England Journal of Medicine2022-05-15107 citations

Efficacy and safety of as-needed albuterol/budesonide versus albuterol in adults and children aged ≥4 years with moderate-to-severe asthma: rationale and design of the randomised, double-blind, active-controlled MANDALA study

BMJ Open Respiratory Research2021-12-0117 citations

Albuterol/budesonide for the treatment of exercise-induced bronchoconstriction in patients with asthma: The TYREE study.

2021-10-244 citations

Dose-Ranging and Cumulative Dose Studies of Albuterol Sulfate MDI in Co-Suspension Delivery™ Technology (AS MDI; PT007) in Patients with Asthma: the ASPEN and ANTORA Trials.

2021-06-044 citations

Phase III Evaluation of the Efficacy and Safety of PT027 (Budesonide/Albuterol pMDI) Compared to Placebo pMDI on Exercise-Induced Bronchoconstriction in Adult and Adolescent Subjects with Asthma: the TYREE Study

2021-05-01